Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice

Open access
FIEDOROWICZ, JESS G., SWARTZ, KAREN L. · 2004 · Journal of Psychiatric Practice

Abstract

The use of monoamine oxidase inhibitors (MAOIs) by psychiatrists has declined over the past several decades with the expansion of psychiatrists' pharmacologic armamentarium. This trend has also been driven by concern about food and drug interactions and side effects, as well as waning physician experience with these medications. Many psychiatrists, in fact, never prescribe MAOIs. Recent research has liberalized the MAOI diet and identified symptom presentations more likely to respond to these medications. Thus, clinicians must continue to familiarize themselves with the properties of and indications for prescribing MAOIs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00131746-200407000-00005

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 117

  1. Kennedy, 1997, J Psychiatry Neurosci, 22, 127
  2. Fava, 2000, J Clin Psychiatry, 61, 26, 10.4088/JCP.v61n0107 · DOI
  3. Nutt, 1989, sychiatry, 154, 287
  4. Petersen, 2002, Prog Neuropsychopharmacol Biol Psychiatry, 26, 177, 10.1016/S0278-5846(01)00250-0 · DOI
  5. Olfson, 1993, Am J Psychiatry, 150, 571, 10.1176/ajp.150.4.571 · DOI
  6. Olfson, 1998, Arch Gen Psychiatry, 55, 310, 10.1001/archpsyc.55.4.310 · DOI · Paper page
  7. Pare, 1985, Br J Psychiatry, 146, 576, 10.1192/bjp.146.6.576 · DOI
  8. 1965, Br J Psychiatry, 1, 881
  9. Robinson, 1978, Arch Gen Psychiatry, 35, 629, 10.1001/archpsyc.1978.01770290111010 · DOI
  10. Balon, 1999, Psychiatr Serv, 50, 945, 10.1176/ps.50.7.945 · DOI
  11. Clary, 1990, J Clin Psychiatry, 51, 226
  12. Fava, 2000, J Clin Psychiatry, 61, 10
  13. Cooper, 1989, Br J Psychiatry, 155, 38, 10.1192/S000712500029747X · DOI
  14. Nierenberg, 2003, J Clin Psychiatry, 52, 383
  15. Zarate, 1995, J Clin Psychiatry, 56, 260
  16. Himmelhoch, 1991, Am J Psychiatry, 148, 910, 10.1176/ajp.148.7.910 · DOI · Paper page
  17. Thase, 1995, Neuropsychopharmacology, 12, 185, 10.1016/0893-133X(94)00058-8 · DOI · Paper page
  18. Kukopulos, 1983, Compr Psychiatry, 24, 249, 10.1016/0010-440X(83)90076-7 · DOI
  19. Amsterdam, 1996, Psychiatr Clin North Am, 19, 371, 10.1016/S0193-953X(05)70293-8 · DOI
  20. Keller, 1982, JAMA, 248, 1848, 10.1001/jama.1982.03330150034019 · DOI · Paper page
  21. Amsterdam, 2001, Psychiatric Annals, 31, 361, 10.3928/0048-5713-20010601-05 · DOI
  22. Guze, 1987, J Clin Psychiatry, 48, 31
  23. Davidson, 1984, J Affect Disord, 6, 201, 10.1016/0165-0327(84)90025-9 · DOI
  24. Ravaris, 1976, Arch Gen Psychiatry, 33, 347, 10.1001/archpsyc.1976.01770030057008 · DOI
  25. Tyrer, 1980, Br J Psychiatry, 136, 359, 10.1192/bjp.136.4.359 · doi:10.1192/bjp.136.4.359
  26. Crane, 1957, Psychiatric Research Reports, 8, 142
  27. West, 1959, BMJ, 1, 1491, 10.1136/bmj.1.5136.1491 · DOI · Paper page
  28. Schildkraut, 1964, Am J Psychiatry, 122, 509, 10.1176/ajp.122.5.509 · DOI · Paper page
  29. Dunlop, 1965, Psychosomatics, VI, 1, 10.1016/S0033-3182(65)72335-9 · doi:10.1016/s0033-3182(65)72335-9
  30. Bymaster, 2003, Expert Opin Investig Drugs, 12, 531, 10.1517/13543784.12.4.531 · DOI
  31. Moreno, 2000, Biol Psychiatry, 48, 327, 10.1016/S0006-3223(00)00893-3 · DOI
  32. Delgado, 1990, Arch Gen Psychiatry, 47, 411, 10.1001/archpsyc.1990.01810170011002 · DOI · Paper page
  33. Livingston, 1996, Drug Saf, 14, 218, 10.2165/00002018-199614040-00002 · DOI · Paper page
  34. Baker, 1992, J Psychiatr Neurosci, 17, 206
  35. Mallinger, 1991, Psychopharmacol Bull, 27, 493
  36. Davidson, 1978, Am J Psychiatry, 135, 470, 10.1176/ajp.135.4.470 · doi:10.1176/ajp.135.4.470
  37. Breshnahan, 1990, J Clin Psychiatry, 51, 47
  38. Raft, 1981, Neuropsychobiology, 7, 122, 10.1159/000117841 · DOI
  39. Bartholomew, 1962, Med J Aust, 49, 655, 10.5694/j.1326-5377.1962.tb26247.x · DOI
  40. Davidson, 1983, J Affect Disord, 5, 183, 10.1016/0165-0327(83)90012-5 · DOI
  41. Escobar, 1974, Am J Psychiatry, 131, 1025, 10.1176/ajp.131.9.1025 · doi:10.1176/ajp.131.9.1025
  42. Evans, 1982, J Clin Psychopharmacol, 2, 208, 10.1097/00004714-198206000-00007 · DOI
  43. Fulton, 1996, Drugs, 52, 450, 10.2165/00003495-199652030-00013 · DOI
  44. Fava, 2000, J Clin Psychiatry, 61, 37
  45. Rabkin, 1984, J Clin Psychopharmacol, 4, 270, 10.1097/00004714-198410000-00007 · DOI
  46. Gomez-Gil, 1996, Ann Intern Med, 124, 692, 10.7326/0003-4819-124-7-199604010-00014 · DOI
  47. Robinson, 2002, Psychopharmacol Bull, 36, 124
  48. Falon, 1988, J Clin Psychiatry, 49, 163
  49. Linet, 1986, J Clin Psychiatry, 47, 563
  50. Lavin, 1993, Biol Psychiatry, 34, 146, 10.1016/0006-3223(93)90384-P · DOI
  51. Fischer, 1995, J Clin Psychopharmacol, 15, 440, 10.1097/00004714-199512000-00009 · doi:10.1097/00004714-199512000-00009
  52. Sternbach, 1991, Am J Psychiatry, 148, 705, 10.1176/ajp.148.6.705 · DOI · Paper page
  53. Neuvonen, 1993, Lancet, 342, 1419, 10.1016/0140-6736(93)92774-N · DOI · Paper page
  54. Linden, 1984, Ann Emerg Med, 13, 1137, 10.1016/S0196-0644(84)80339-X · doi:10.1016/s0196-0644(84)80339-x
  55. Baker, 1999, Cell Mol Neurobiol, 19, 411, 10.1023/A:1006982732681 · doi:10.1023/a:1006982732681
  56. Kita, 2003, Biol Pharm Bull, 26, 386, 10.1248/bpb.26.386 · doi:10.1248/bpb.26.386
  57. Marangell, 2001, J Clin Psychiatry, 62, 12, 10.4088/JCP.v62n0104 · DOI · Paper page
  58. Gitlin, 1997, J Clin Psychopharmacol, 17, 66, 10.1097/00004714-199702000-00022 · doi:10.1097/00004714-199702000-00022
  59. Szuba, 1997, J Clin Psychiatry, 58, 307, 10.4088/JCP.v58n0704 · DOI
  60. Bodner, 1995, Neurology, 45, 219, 10.1212/WNL.45.2.219 · doi:10.1212/wnl.45.2.219
  61. Volz, 1998, Drugs Aging, 13, 341, 10.2165/00002512-199813050-00002 · DOI
  62. Noorily, 1997, South Med J, 90, 836, 10.1097/00007611-199708000-00014 · DOI
  63. Pope, 1985, Am J Psychiatry, 142, 491, 10.1176/ajp.142.4.491 · doi:10.1176/ajp.142.4.491
  64. Livingston, 1995, Lancet, 345, 533, 10.1016/S0140-6736(95)90460-3 · doi:10.1016/s0140-6736(95)90460-3
  65. Hammerness, 2002, Psychosomatics, 43, 248, 10.1176/appi.psy.43.3.248-a · DOI
  66. Sullivan, 1984, Can J Psychiatry, 29, 707, 10.1177/070674378402900814 · DOI
  67. Blackwell, 1963, Lancet, II, 849, 10.1016/S0140-6736(63)92743-0 · DOI · Paper page
  68. Blackwell, 1967, Br J Psychiatry, 113, 349, 10.1192/bjp.113.497.349 · DOI · Paper page
  69. Gardner, 1996, J Clin Psychiatry, 57, 99
  70. McCabe, 1982, J Clin Psychiatry, 43, 178
  71. Shulman, 1989, J Clin Psychopharmacol, 9, 397, 10.1097/00004714-198912000-00002 · DOI
  72. Shulman, 1999, J Clin Psychiatry, 60, 191, 10.4088/JCP.v60n0308 · DOI
  73. Shulman, 1997, Can J Psychiatry, 42, 310, 10.1177/070674379704200311 · doi:10.1177/070674379704200311
  74. Walker, 1996, J Clin Psychopharmacol, 16, 383, 10.1097/00004714-199610000-00007 · DOI
  75. Bieck, 1988, J Clin Psychiatry, 8, 237
  76. Feinberg, 2000, J Clin Psychiatry, 61, 145, 10.4088/JCP.v61n0211c · doi:10.4088/jcp.v61n0211c
  77. Folks, 1983, J Clin Psychopharmacol, 3, 249, 10.1097/00004714-198308000-00011 · DOI
  78. Neil, 1979, J Clin Psychiatry, 40, 33
  79. Sweet, 1995, sychiatry, 56, 196
  80. Clayton, 1998, J Clin Psychiatry, 59, 5
  81. Nierenberg, 1998, J Clin Psychiatry, 59, 5
  82. Liebowitz, 1993, J Clin Psychiatry, 52, 10
  83. Parker, 2002, Am J Psychiatry, 159, 1470, 10.1176/appi.ajp.159.9.1470 · DOI · Paper page
  84. Lam, 1996, Compr Psychiatry, 37, 375, 10.1016/S0010-440X(96)90020-6 · DOI
  85. Davidson, 1987, J Clin Psychiatry, 48, 143
  86. Davidson, 1986, Psychiatry Res, 17, 87, 10.1016/0165-1781(86)90063-6 · DOI
  87. Liebowitz, 1988, Arch Gen Psychiatry, 45, 129, 10.1001/archpsyc.1988.01800260037004 · DOI · Paper page
  88. Liebowitz, 1984, Arch Gen Psychiatry, 41, 669, 10.1001/archpsyc.1984.01790180039005 · DOI · Paper page
  89. McGrath, 1993, Am J Psychiatry, 150, 118, 10.1176/ajp.150.1.118 · DOI
  90. Quitkin, 1993, Br J Psychiatry, 163, 30, 10.1192/S0007125000292465 · DOI · Paper page
  91. Stewart, 2002, europsychopharmacology, 26, 237, 10.1016/S0893-133X(01)00313-X · DOI
  92. Thase, 1991, Psychopharmacol Bull, 27, 17
  93. Davidson, 1982, Arch Gen Psychiatry, 39, 527, 10.1001/archpsyc.1982.04290050015005 · DOI
  94. Paykel, 1982, Arch Gen Psychiatry, 39, 1041, 10.1001/archpsyc.1982.04290090035008 · DOI
  95. White, 1984, Psychopharmacology, 82, 258, 10.1007/BF00427786 · DOI
  96. Pande, 1996, Biol Psychiatry, 40, 1017, 10.1016/0006-3223(95)00628-1 · DOI
  97. Stoll, 1994, Am J Psychiatry, 151, 1642, 10.1176/ajp.151.11.1642 · DOI
  98. Davidson, 1988, Arch Gen Psychiatry, 45, 120, 10.1001/archpsyc.1988.01800260024003 · DOI
  99. Kay, 1973, Br J Psychiatry, 123, 63, 10.1192/bjp.123.1.63 · doi:10.1192/bjp.123.1.63
  100. Reynaert, 1995, Psychopharmacology, 118, 183, 10.1007/BF02245838 · DOI
  101. Georgotas, 1987, Br J Psychiatry, 151, 102, 10.1192/bjp.151.1.102 · DOI
  102. Georgotas, 1986, Biol Psychiatry, 21, 1155, 10.1016/0006-3223(86)90222-2 · DOI
  103. McGrath, 1987, Psychopharmacol Bull, 23, 169
  104. Himmelhoch, 1972, J Nerv Ment Dis, 155, 216, 10.1097/00005053-197209000-00009 · DOI
  105. Thase, 1992, J Clin Psychiatry, 53, 5
  106. Nolen, 1988, Acta Psychiatr, 78, 676, 10.1111/j.1600-0447.1988.tb06403.x · DOI
  107. Kahn, 1989, J Clin Psychopharmacol, 9, 198, 10.1097/00004714-198906000-00007 · doi:10.1097/00004714-198906000-00007
  108. Ebert, 1995, Psychopharmacology, 119, 342, 10.1007/BF02246301 · DOI
  109. Lotufo-Neto, 1999, Neuropsychopharmacology, 20, 226, 10.1016/S0893-133X(98)00075-X · DOI · Paper page
  110. Amsterdam, 2003, J Clin Psychiatry, 64, 208, 10.4088/JCP.v64n0216 · DOI
  111. Bodkin, 2002, Am J Psychiatry, 159, 1869, 10.1176/appi.ajp.159.11.1869 · DOI · Paper page
  112. Sunderland, 1994, Arch Gen Psychiatry, 51, 607, 10.1001/archpsyc.1994.03950080019003 · DOI
  113. Mann, 1989, Arch Gen Psychiatry, 46, 45, 10.1001/archpsyc.1989.01810010047007 · DOI · Paper page
  114. McGrath, 1989, Psychophar-macol Bull, 25, 63
  115. Pierre, 2000, J Clin Psychiatry, 61, 450, 10.4088/JCP.v61n0610h · DOI
  116. Davidson, 1982, J Clin Psychopharmacol, 2, 216, 10.1097/00004714-198206000-00010 · doi:10.1097/00004714-198206000-00010
  117. Nierenberg, 1990, J Clin Psychiatry, 51, 39

Cited by

See all 164

Metadata

Authors
FIEDOROWICZ, J. G., & SWARTZ, K. L.
Venue
Journal of Psychiatric Practice
Published
2004-07
Volume
10
Issue
4
Pages
239-248
ISSN
  • 1527-4160 (ISSN-L)
  • 1538-1145
OpenAlex
W2038208465
Cited by
164
References
1
FWCI
1.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice. https://app.cochat.ai/papers/10.1097/00131746-200407000-00005
The paper
FIEDOROWICZ, J. G., & SWARTZ, K. L. (2004). The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice. Journal of Psychiatric Practice. https://doi.org/10.1097/00131746-200407000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.